Related Experiment Video
Updated: Jan 10, 2026

Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
Environmental factors contribute to cancer therapy toxicity
Abstract:
Cancer therapy-related cognitive impairment (CRCI) affects numerous cancer patients, however there is substantial variability in its severity. Here, we investigated how environmental factors such as housing facility and time of treatment, known as chronotherapy, impact chemotoxicity in a pediatric murine model of methotrexate (MTX)-induced CRCI. We find that MTX consistently impacts body mass in a time-of-day specific manner across different housing facilities. Intriguingly, investigation of the gut microbiome acutely after MTX chronotherapy revealed substantial differences in microbial composition between animals housed in different facilities as well as decreased microbial diversity at different times of day. Furthermore, these differences in the gut microbiome after MTX chronotherapy coincide with differences in circulating inflammatory cytokine profiles between facilities and times of day. Chronically, housing facility continued to impact serum cytokine levels after MTX treatment, whereas the effect of time wanes. Nonetheless, we found that time drastically alters chronic white matter microglial gene expression in the central nervous system (CNS) after MTX treatment. Together, these findings demonstrate that both housing facility and time dictate response to MTX chronotherapy in the periphery and CNS. Collectively, this work elucidates putative factors that can regulate MTX-induced chemotoxicity.
Related Concept Videos
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

